CSF levels of Aβ42, tau, and hyperphosphorylated tau (ptau) as markers for amyloid, neuronal injury, and tangles, respectively, have been the main fluid biomarkers used in AD research (30, 31). This evidence concerns the gene MAPT and Alzheimer disease.